AxoGen, Inc.
AXGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $187 | $159 | $139 | $127 |
| % Growth | 17.8% | 14.7% | 8.8% | – |
| Cost of Goods Sold | $45 | $37 | $30 | $23 |
| Gross Profit | $142 | $122 | $109 | $104 |
| % Margin | 75.8% | 76.6% | 78.5% | 82% |
| R&D Expenses | $28 | $27 | $26 | $24 |
| G&A Expenses | $39 | $38 | $41 | $32 |
| SG&A Expenses | $117 | $116 | $113 | $106 |
| Sales & Mktg Exp. | $78 | $78 | $72 | $73 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $145 | $143 | $139 | $130 |
| Operating Income | -$3 | -$21 | -$30 | -$25 |
| % Margin | -1.8% | -13.5% | -21.4% | -20% |
| Other Income/Exp. Net | -$7 | -$0 | $1 | -$2 |
| Pre-Tax Income | -$10 | -$22 | -$29 | -$27 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$22 | -$29 | -$27 |
| % Margin | -5.3% | -13.7% | -20.9% | -21.2% |
| EPS | -0.23 | -0.51 | -0.69 | -0.65 |
| % Growth | 54.9% | 26.1% | -6.2% | – |
| EPS Diluted | -0.23 | -0.51 | -0.69 | -0.65 |
| Weighted Avg Shares Out | 44 | 43 | 42 | 41 |
| Weighted Avg Shares Out Dil | 44 | 43 | 42 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $8 | $3 | $1 | $1 |
| Depreciation & Amortization | $8 | $6 | $5 | $5 |
| EBITDA | $6 | -$13 | -$23 | -$21 |
| % Margin | 3.2% | -8.4% | -16.9% | -16.4% |